about
Management of Multiple Sclerosis in the Breastfeeding MotherDrug-induced renal damage in preterm neonates: state of the art and methods for early detectionDevelopmental pharmacokinetics in pediatric populationsOrgan data from the developing Göttingen minipig: first steps towards a juvenile PBPK model.Bisphenol A data in NHANES suggest longer than expected half-life, substantial nonfood exposure, or bothSafety and efficacy of gadobutrol-enhanced MRI in patients aged under 2 years-a single-center, observational study.Drug-induced hepatic injury in children: a case/non-case study of suspected adverse drug reactions in VigiBase.The role of protein digestibility and antacids on food allergy outcomes.ASAP ECMO: Antibiotic, Sedative and Analgesic Pharmacokinetics during Extracorporeal Membrane Oxygenation: a multi-centre study to optimise drug therapy during ECMO.Vancomycin population pharmacokinetics during extracorporeal membrane oxygenation therapy: a matched cohort studyThe Role of Pharmacokinetics and Pharmacodynamics in Early Drug Development with reference to the Cyclin-dependent Kinase (Cdk) Inhibitor - RoscovitineDevelopment of a Pediatric Physiologically Based Pharmacokinetic Model for Sirolimus: Applying Principles of Growth and Maturation in Neonates and Infants.Early Life Metabolism of Bisphenol A: A Systematic Review of the LiteratureClomipramine concentration and withdrawal symptoms in 10 neonates.Pharmacokinetics of penicillin g in very-low-birth-weight neonates.Special population considerations and regulatory affairs for clinical researchClinical Pharmacology Studies in Critically Ill Children.Computational pharmacokinetics during developmental windows of susceptibility.Population pharmacokinetics of etomidate in neonates and infants with congenital heart disease.Effect of Kidney Function on Drug Kinetics and Dosing in Neonates, Infants, and ChildrenTreating disorders of the neonatal central nervous system: pharmacokinetic and pharmacodynamic considerations with a focus on antiepileptics.Development of PBPK models for PFOA and PFOS for human pregnancy and lactation life stages.Urinary free bisphenol A and bisphenol A-glucuronide concentrations in newbornsSequestration of drugs in the circuit may lead to therapeutic failure during extracorporeal membrane oxygenationPopulation Pharmacokinetics of Oral Topotecan in Infants and Very Young Children with Brain Tumors Demonstrates a Role of ABCG2 rs4148157 on the Absorption Rate Constant.Exposure to chemical cocktails before or after conception--- the effect of timing on ovarian development.Integration of Life-Stage Physiologically Based Pharmacokinetic Models with Adverse Outcome Pathways and Environmental Exposure Models to Screen for Environmental Hazards.Epidemiology of Polypharmacy and Potential Drug-Drug Interactions Among Pediatric Patients in ICUs of U.S. Children's Hospitals.Pediatric Dosing and Body Size in Biotherapeutics.Determination of vancomycin pharmacokinetics in neonates to develop practical initial dosing recommendations.Bisphenol A-associated alterations in the expression and epigenetic regulation of genes encoding xenobiotic metabolizing enzymes in human fetal liver.A reappraisal of current dosing strategies for intravenous fosfomycin in children and neonates.Neonatal pharmacology: extensive interindividual variability despite limited size.Ontogeny of mammalian metabolizing enzymes in humans and animals used in toxicological studies.Development of the Digestive System-Experimental Challenges and Approaches of Infant Lipid Digestion.Similarities and differences in gastrointestinal physiology between neonates and adults: a physiologically based pharmacokinetic modeling perspective.Pharmacokinetics and pharmacokinetic-pharmacodynamic relationships of monoclonal antibodies in children.Assessment of health risks resulting from early-life exposures: Are current chemical toxicity testing protocols and risk assessment methods adequate?A Review of Adverse Reactions in Infants From Medications in Breastmilk.Challenges Associated with Route of Administration in Neonatal Drug Delivery.
P2860
Q26766337-1B588AC7-523C-4117-8DA0-D5CC3889A655Q26849339-74A23DAC-B72D-4B18-A4DD-CE9337A8AD87Q27002933-89AD01CC-83F1-4904-A68E-FE73DD196F5AQ31033069-00F79BE2-3CD4-4434-8989-2068BAA09D51Q33455659-111B8C98-B964-4438-AE61-BFCA2B2A839DQ33873742-0736861B-A629-431F-8F0A-FAD508E5C44CQ34381361-4A3D6FCB-E08A-47B5-B0D2-F7939C116F6AQ34394239-2D369C68-5D0C-438B-9199-FC82D0077E43Q34494688-3C40A218-2CAE-41F8-90DD-740CBEBA18F8Q34636783-61388B49-B409-40B1-9F7E-31097FD7CF3BQ35062145-15E493F5-3BB9-424C-80F9-96B46EB35A54Q35179536-29D4CE04-5D3D-414F-80F0-9C2A8B0AE070Q35234895-55A60BA4-DF6E-414B-938E-9BA142E9A861Q35718651-E92E6497-7E71-46A0-826F-6F963FB7E060Q35840847-25F8C95D-3B6B-476A-AB2E-E543A6D2CD53Q36078698-2ECB680F-C22D-49D1-A4CB-1CCC22EBB0C1Q36120465-B4608EC1-FA68-4D8E-A5DD-C9180C998EE9Q36195215-D9ADA9B6-00FD-42DE-9385-5EBCD02FBA2AQ36239801-50194170-9EB4-4771-91C7-488AA6ACA2E5Q36322918-9FDBE192-B9AC-4E52-B1D2-460FF204EFEBQ36410220-E90AF6FE-75F1-4A15-A75C-6A25AC094A60Q36411181-81E19E7F-6CDF-4BD9-AC6B-F3D27430D154Q36721563-B0F2ECAE-090C-425D-986A-A83057166074Q36928231-CEB36A41-EA3F-4618-AEC2-5D0A074F8F05Q37062610-84C77291-DF9B-42BF-8223-59446822E082Q37064622-E9F94E7F-98FB-4396-8B37-E783E1BC3A32Q37228208-4C924533-0B6E-4F56-B70D-328DE7794DA2Q37592428-F8538413-289C-4FE6-811F-3949DE59937BQ37666711-3D9A596C-59B3-44BE-86D6-5E2615EA461EQ37712974-55963CA8-958F-497B-A37E-7610E86435ECQ37723732-E043F445-E3F0-4653-9F1B-4F976DE5D9B7Q37899151-0F22018C-D596-47B1-B2CC-EADB0265DBC4Q38000252-99A04032-4DF2-4797-A372-2DE4ADAE6ACEQ38003479-96ED3404-C98C-4560-A7DE-A620F909E03FQ38072044-B84327B5-5DC5-466B-A671-485E8DBE56ABQ38245572-0CB5D058-A944-4172-8CD3-A2534768EA62Q38291356-458D8A1E-3694-4628-807A-0B0A0E8DCBACQ38357598-EFDAF8A0-45EA-4FD4-AD05-BBECB83066A2Q38546439-1F871A4E-7A25-4D58-B1A0-323E91FDD74AQ38561363-C4683F42-4FF3-4555-9530-CEC7722B586E
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Pharmacokinetics in the newborn.
@ast
Pharmacokinetics in the newborn.
@en
type
label
Pharmacokinetics in the newborn.
@ast
Pharmacokinetics in the newborn.
@en
prefLabel
Pharmacokinetics in the newborn.
@ast
Pharmacokinetics in the newborn.
@en
P1476
Pharmacokinetics in the newborn.
@en
P2093
Jane Alcorn
Patrick J McNamara
P304
P356
10.1016/S0169-409X(03)00030-9
P407
P577
2003-04-01T00:00:00Z